Detalhes bibliográficos
| Ano de defesa: |
2015 |
| Autor(a) principal: |
Guimarães, Camila Diniz Branquinho
 |
| Orientador(a): |
Rosso, Claci Fátima Weirich
|
| Banca de defesa: |
Rosso, Claci Fátima Weirich,
Dewulf, Nathalie de Lourdes Souza,
Souza, Marta Rovery de |
| Tipo de documento: |
Dissertação
|
| Tipo de acesso: |
Acesso aberto |
| Idioma: |
por |
| Instituição de defesa: |
Universidade Federal de Goiás
|
| Programa de Pós-Graduação: |
Programa de Pós-graduação em Saúde Coletiva (PRPG)
|
| Departamento: |
Pró-Reitoria de Pós-graduação (PRPG)
|
| País: |
Brasil
|
| Palavras-chave em Português: |
|
| Palavras-chave em Inglês: |
|
| Área do conhecimento CNPq: |
|
| Link de acesso: |
http://repositorio.bc.ufg.br/tede/handle/tede/5443
|
Resumo: |
The National Drug Policy aims to guarantee people's access to essential drugs. In order to make possible the evaluation of drugs availability, WHO developed and disseminated lists of principle essential drugs or tracers that function as markers that allow monitoring. This study aimed to analyze the tracer drugs availability, in primary health care services, evaluated in Program for Access and Quality Improvement. This is a descriptive cross-sectional study, using secondary data from national database of the external evaluation of the Program for Access and Quality Improvement in Primary Care (PMAQ-AB) carried out in 41 Primary Health Care facilities at the city that’s hub of pharmaceutical industry in the country. The lists of tracer drugs (global list and regional list) proposed by WHO in 2008 were used to select the variables analyzed in this study. The main finding related to organizational factors was the presence of pharmacies in the Basic Health Units (BHU) without storage rooms. The average of availability for all tracer drugs investigated was 51.41%, lower than the acceptable value proposed by WHO. Not all BHU who said they had the drug in stock, have had them enough to meet the demands of the population. About controlled tracer drugs, they were unavailable in all the Basic Health Units (BHU). It was concluded that the availability of essential tracer drugs do not meet the demand of primary care despite of being on the city that’s pole of the pharmaceutical industry. Local managers have rethink processes and the organization of Pharmaceutical Services, including human resources, since these essential drugs should be available in all BHU in sufficient quantity to meet the population's needs. |
